Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2003
10/28/2003US6638529 Lipid copound for use in the transfer macromolecules in cells
10/28/2003CA2101179C Phenylimidazolidine derivatives, their preparation and their use
10/28/2003CA2058020C Short peptides with insulin activity
10/23/2003WO2003087137A2 New therapeutic uses of tri-, tetra-, penta-, and polypeptides
10/23/2003WO2003087092A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
10/23/2003WO2003087070A2 Growth hormone secretagogues
10/23/2003WO2003087069A2 Dipeptidic growth hormone secretagogues
10/23/2003WO2003087054A2 Methods for identifying compounds that modulate enzymatic activity
10/23/2003WO2003087050A2 Novel perindopril salt and pharmaceutical compositions containing same
10/23/2003WO2003086470A2 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/23/2003WO2002099099A3 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications
10/23/2003WO2001079267A9 A glycopeptide and preparation thereof
10/23/2003WO2001079195A9 Pyridine and pyrazine derivatives as thrombin inhibitors
10/23/2003US20030200555 For Alzheimer's disease diagnosis, treatment
10/23/2003US20030199676 Effective for proteins expressed in bacteria as inclusion bodies
10/23/2003US20030199568 Salt of perindopril and pharmaceutical compositions containing it
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199506 An enzyme inhibitor of cysteine proteases, a morpholine-4-carboxyamide 1,3,4-oxadiazole derivatives; for treating arthritis, muscular dystrophy, inflammation, tumor, glomerulonephritis, malaria, periodontal disease
10/23/2003US20030199455 Thrombolytic agents, restenosis, hypotension agents, heart failure, antiarrhythmia and -inflammation agents, angina, stroke, atherosclerosis, antiischemic agents, angiogenesis related disorders, anti carcinogenic and -tumor agents
10/23/2003US20030198989 For use as a diagnostic reagent for detecting the presence or absence of a target molecule in a sample; Systematic Evolution of Ligands by EXponential enrichment (SELEX)
10/23/2003US20030198617 Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
10/23/2003CA2478398A1 Methods for identifying compounds that modulate enzymatic activity
10/22/2003EP1354953A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354952A1 Smac-peptides as therapeutics against cancer and autoimmune diseases
10/22/2003EP1354876A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof; and use in the synthesis of perindopril
10/22/2003EP1354875A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof; and use in the synthesis of perindopril
10/22/2003EP1354874A1 Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof; and use in the synthesis of perindopril
10/22/2003EP1354873A1 Salt of perindopril and pharmaceutical compositions containing it
10/22/2003EP1353939A2 Tetrapeptide regulating prostate functions and its compositions and methods
10/22/2003EP1353929A2 Streptogramin derivatives preparation thereof and compositions containing same
10/22/2003EP1353683A2 Ghrelin analogs
10/22/2003EP1204676B1 Streptogramin derivatives, preparation and compositions containing same
10/22/2003EP1180121B1 Long lasting insulinotropic peptides
10/22/2003EP0764167B1 Bicycling lactam inhibitor of interleukin-1-beta converting enzyme
10/22/2003CN1451014A Peptidomimetic protease inhibitors
10/22/2003CN1450915A Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
10/22/2003CN1125054C Novel imidazolidine derivatives, their preparation their use and pharmaceutical preparations comprising them
10/22/2003CN1125040C Therapeutic compound-fatty acid conjugates
10/21/2003US6635752 Diagnosis of Aids
10/21/2003US6635621 Alpha amino acid amide derivatives; reducing cathepsins B, L, S and/or K activity
10/21/2003US6635620 Hydroxyproline derivatives
10/21/2003US6635432 Administering a composition to cells and determining if it enhances or inhibits opening; tetrapeptide with amide group at carboxy end; electrophysical analysis
10/21/2003CA2273989C New histidine derivatives, preparation process, and their use as free antiradical agents
10/21/2003CA2197000C Surface-modifying copolymers having cell adhesion properties
10/21/2003CA2098020C Anti-viral compounds
10/16/2003WO2003084984A1 Heterocyclic amides with alpha-4 integrin antagonist activity
10/16/2003WO2003012127A3 Assay for identifying inhibitors of hiv rt dimerization
10/16/2003WO2002098905A3 Enzymatic coupling of l-phenylalanine methyl ester and n-benzyloxycarbonyl-l-aspartic acid in a continuous or fed-batch process
10/16/2003US20030195362 For therapy of retroviral infection and in particular an HIV infection
10/16/2003US20030195361 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
10/16/2003US20030195331 In situ chlorination, to generate amino acid chlorides, utilizing for solid phase peptide synthesis
10/16/2003US20030195227 Retroviral protease inhibitors
10/16/2003US20030195173 Colchinol derivatives as angiogenesis inhibitors
10/16/2003US20030195159 HIV protease inhibitors based on amino acid derivatives
10/16/2003US20030195156 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
10/16/2003US20030195152 Polymeric conjugates of antitumor agents
10/16/2003US20030195146 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages
10/16/2003US20030195144 Antimicrobial compounds and formulations
10/16/2003US20030195141 Anti-inflammatory peptides
10/16/2003US20030194743 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194375 Anti-epileptogenic agents
10/16/2003CA2477943A1 Heterocyclic amides with alpha-4 integrin antagonist activity
10/15/2003EP1351992A2 Hybrid peptides for treatment of bacteremia and septicemia
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
10/15/2003EP1351976A2 Gpe analogs
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351932A2 N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351695A1 Camptothecin compounds with a sulfhydryl group
10/15/2003EP1110088B1 Energy transfer dyes
10/15/2003CN1449409A Promyostatin peptides and methods of using same
10/15/2003CN1449408A Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/14/2003US6632921 Administering as topical fungicide against Candida
10/14/2003US6632795 Treatment of cancer
10/14/2003US6632626 Cancer; anticarcinogenic agents; use of purified enzyme in screening protocols for the identification of possible anti-cancer agents which inhibit the enzyme and thereby prevent expression of the oncogenic ras proteins such as p21ras
10/14/2003US6632616 A peptide or polypeptide containing tryptophan and a charged amino acid selected from lysine, arganine and histidine and the compound is conjugated to a detactable group, useful to detect an expanded polyglutamine doamine in a sample
10/14/2003US6632438 Vaccines
10/14/2003CA2286750C Application and production process of a group of anticancer compounds
10/09/2003WO2003083055A2 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents
10/09/2003WO2003082906A2 Neurotrophic and neuroprotective peptides
10/09/2003WO2003082905A1 Plant retroviral polynucleotides and methods for use thereof
10/09/2003WO2003082809A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
10/09/2003WO2003082268A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003014076A3 Bi-directional synthesis of oligoguanidine transport agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191305 Reacting a 16-sulphonyloxy substituted sterptogramin derivative with alkali metal cyanide, and reducing the compound obtained from the solution
10/09/2003US20030191139 Anticoagulant for mammals
10/09/2003US20030191109 Beta-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
10/09/2003US20030191068 Salts of the CGRP antagonist BIBN4096 and inhalable powdered medicaments containing them
10/09/2003US20030191067 Hepatitis C inhibitor tri-peptides
10/09/2003US20030191066 Side effect reduction; anticancer agents
10/09/2003US20030191053 Cyclic peptide derivative
10/09/2003US20030191049 Oligomers of nonpeptide restricted mimetics of dipeptides of tripeptides, and the use thereof in the synthesis of synthetic proteins and polypeptides
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 307